GTC presented abstracts at the 2025 Annual Meeting of the Society for Neuro-Oncology (SNO).
GTC participated in the 30th Annual Meeting & Education Day of the Society for Neuro-Oncology (SNO), held at the Hawaii Convention Center in Honolulu, November 19–23, 2025. Our two presented posters are now available for download. For scientific clarification or collaboration inquiries, please contact us directly.
Using cell free DNA (cfDNA) and RNA (cfRNA) in the diagnosis and monitoring of primary and metastatic CNS tumors - Abstract Code: INNV-08
Monitoring therapy in leptomeningeal carcinomatosis in colorectal cancer using CSF liquid biopsy.- Abstract Code: BIOM40
Read more Articles and News from GTC
Genomic Testing Cooperative (GTC) to Share 12 Ground-breaking Abstracts at the 2025 American Society of Hematology (ASH) Annual Meeting in Orlando
Lake Forest, CA — December 2, 2025 — Genomic Testing Cooperative (GTC), a leading provider of integrated DNA and RNA next-generation sequencing (NGS) solutions for
SNO 25 Posters
GTC presented abstracts at the 2025 Annual Meeting of the Society for Neuro-Oncology (SNO). GTC participated in the 30th Annual Meeting & Education Day of
67th ASH® Annual Meeting Posters
GTC posters at 67th ASH® Annual Meeting (2025) We are delighted to share that GTC’s work and data will be presented in 12 abstracts at
Peripheral Blood Tumor Associated Cell-Free DNA Testing as a Predictor for Relapse Postallogeneic Stem Cell Transplant for Acute Myelogenous Leukemia
Authors: Vanisha Patel1,*, Maciej Kabat1, Andrew Ip2, Sukhdeep Kaur2, Hyung Chan Suh2, Christina Cho2, David Vesole2, Michele Donato2, Maher Albitar2, Scott D. Rowley2 Affiliations:1Hackensack University
ASH 67th Annual Meeting & Exposition
The largest gathering in hematology, combining scientific sessions, poster presentations, and exhibits with abstracts submission available until August 5, 2025
SNO (Society for Neuro‑Oncology) Annual Meeting
The premier neuro-oncology conference featuring the World Federation of Neuro-Oncology and Society for Neuro-Oncology quadrennial meeting, highlighting advances in brain tumor research and clinical practice.